JPRN-UMIN000054057
Recruiting
未知
Single-center prospective observational study investigating the impact of chronic inflammation on drug responsiveness in heart failure patients - Observational study of heart failure patients with chronic inflammation
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hamamatsu University School of Medicine
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have had a heart failure event within the past 4 weeks Patients with infectious diseases Patients with cancer Patients with significantly poor medication adherence
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Saroglitazar vs obeticholic acid in patients of fatty liver.Health Condition 1: K740- Hepatic fibrosisCTRI/2023/03/050213Department of Medical gastroenterology
Completed
Not Applicable
FLUid intervention and Renal Outcome TRIAL in patients undergoing major surgery: an observational single-centred study (The FLURO TRIAL)Acute Renal InjuryFluid InterventionChnages in plasma chlorideChnages in acid base statusAnaesthesiology - AnaestheticsSurgery - Other surgeryRenal and Urogenital - Kidney diseaseACTRN12614000666628Austin Hospital500
Not yet recruiting
Not Applicable
Accuracy of continuous glucose monitoring in cardiac surgeryNot ApplicableKCT0009396The Catholic University of Korea, Seoul St. Mary's Hospital42
Not yet recruiting
Not Applicable
A single-centre prospective observational study into development of microcirculatory alterations and response to therapy in adult critically ill patientsNL-OMON40618Erasmus MC, Universitair Medisch Centrum Rotterdam168
Not yet recruiting
Not Applicable
Observational prospective single center study for the usefulness of AminoIndex cancer risk screening (AICS) in early gastric cancerEarly gastric cancerJPRN-UMIN000033733Yokohama City University Center for Novel and Exploratory Clinical Trials90